Global Antisense & RNAi Therapeutics Market Trends And Strategies Of Major Players In The Antisense & RNAi Therapeutics Market 2021-2030
16 Feb, 2021
The antisense & RNAi therapeutics market consists of sales of antisense & RNAi therapeutics products and related services by entities (organizations, sole traders and partnerships) that develop antisense & RNAi therapeutics to treat various diseases. RNA interference (RNAi)-based and RNA-based antisense oligonucleotide therapies are advanced methods used for the treatment of various respiratory diseases including chronic obstructive pulmonary disease (COPD) and asthma. In addition to this, antisense & RNAi therapeutics finds its application in curing cancer, infectious diseases, cardiovascular diseases, and genetic disorders.
Global Antisense & RNAi Therapeutics Market Size And Drivers:
The global antisense & RNAi therapeutics market is expected to grow from $1.11 billion in 2020 to $1.2 billion in 2021 at a compound annual growth rate (CAGR) of 8.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $1.79 billion in 2025 at a CAGR of 11%. The rising prevalence of coronary artery diseases, neurodegenerative disorders, and infectious diseases is projected to contribute to the demand for the antisense & RNAi therapeutics market.
Request For A Sample For The Global Antisense & RNAi Therapeutics Market Report:
Trends In The Global Antisense & RNAi Therapeutics Market
Major companies operating in the antisense & RNAi therapeutics market are undertaking strategic initiatives such as collaborations and partnerships for product innovation to sustain in the increasingly competitive market, companies are developing innovative products as well as sharing skills and expertise with other companies.
Global Antisense & RNAi Therapeutics Market Segments:
The global antisense & RNAi therapeutics market is further segmented based on type, technology, route of administration, indication and geography.
By Technology:RNA Interference, Antisense RNA.
By Route of Administration:Pulmonary Delivery, Intravenous Injections, Intra-Dermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods.
By Indication:Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Others.
By Geography: The global antisense & RNAi therapeutics market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Antisense & RNAi Therapeutics Market At:
Antisense & RNAi Therapeutics Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides antisense & RNAi therapeutics market overviews, analyzes and forecasts market size and growth for the global antisense & RNAi therapeutics market, antisense & RNAi therapeutics market share, antisense & RNAi therapeutics market players, antisense & RNAi therapeutics market segments and geographies, antisense & RNAi therapeutics market’s leading competitors’ revenues, profiles and market shares. The antisense & RNAi therapeutics market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.